Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Exousia Bio (LMMY) Free Cash Flow (2022 - 2025)

Lamy (LMMY) has disclosed Free Cash Flow for 4 consecutive years, with $172456.0 as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 93.87% to $172456.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $84890.0 through Nov 2025, up 1.41% year-over-year, with the annual reading at -$4528.0 for FY2025, 63.73% up from the prior year.
  • Free Cash Flow hit $172456.0 in Q4 2025 for Lamy, up from $3500.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $172456.0 in Q4 2025 to a low of -$87566.0 in Q1 2025.
  • Historically, Free Cash Flow has averaged $8630.9 across 4 years, with a median of -$2060.5 in 2023.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 5320.36% in 2024 and later plummeted 6088.41% in 2025.
  • Year by year, Free Cash Flow stood at -$4731.0 in 2022, then skyrocketed by 63.98% to -$1704.0 in 2023, then surged by 5320.36% to $88955.0 in 2024, then soared by 93.87% to $172456.0 in 2025.
  • Business Quant data shows Free Cash Flow for LMMY at $172456.0 in Q4 2025, $3500.0 in Q3 2025, and -$3500.0 in Q2 2025.